Rare diseases
Investigational molecules
Locations
Back to France1 417 clinical trials in Beuvry, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Study on Long-Term Safety and Effectiveness of Upadacitinib for Patients with Ulcerative Colitis
FranceStudy on Pembrolizumab and Lenvatinib for Patients with Pre-Treated Thymic Carcinoma and B3-Thymoma
FranceStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
FranceStudy of Venetoclax and Azacitidine for Patients with Acute Myeloid Leukemia After Stem Cell Transplant
FranceStudy on Lenalidomide, Tafasitamab, and Rituximab for Treating Diffuse Large B-Cell Lymphoma in Patients Aged 80 and Older
FranceStudy Comparing Venetoclax and Dexamethasone with Pomalidomide and Dexamethasone for Patients with Relapsed or Refractory Multiple Myeloma
FranceStudy of Bepirovirsen for Patients with Chronic Hepatitis B on Nucleos(t)ide Analogue Treatment
FranceStudy Comparing Chemotherapy with Docetaxel, Cisplatin, and Fluorouracil to Standard Treatment for Patients with Advanced Anal Cancer
FranceStudy on Giredestrant and Fulvestrant with CDK4/6 Inhibitor for Patients with ER+ HER2-Negative Advanced Breast Cancer Resistant to Endocrine Therapy
FranceStudy of BMS-986466 with Adagrasib and Cetuximab for Patients with KRAS G12C-mutant Advanced Solid Tumors
FranceStudy on Baricitinib for Hospitalized Patients with Severe or Critical COVID-19
FranceStudy on the Effectiveness and Safety of Bemcentinib for Hospitalized Patients with Moderate COVID-19
FranceThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on gastrointestinal cancers, including studies evaluating novel treatments for esophageal squamous cell carcinoma and advanced colorectal cancer. Research includes innovative combination therapies and targeted treatments for specific genetic mutations.
Innovative studies examining treatments for non-small cell lung cancer, including immunotherapy combinations and radiation therapy approaches. Research focuses on improving outcomes for patients with advanced disease stages.
Comprehensive research into hormone-dependent cancers, investigating new treatment approaches for castrate-resistant prostate cancer and ER+/HER2- breast cancer. Studies include both early-stage and advanced disease management.
Studies examining treatments for respiratory tract infections and severe infections in intensive care settings. Research includes antibiotic alternatives and management strategies for septic shock.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
